Milrinone Lactate Injection, Solution
Product Images NDC 0143-9709

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Milrinone Lactate (NDC 0143-9709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Milrinone Lactate Injection 1)

Chemical structure of Milrinone Lactate, showing its molecular framework including a pyridine ring, cyano group, and lactone ring as part of its core structure.*

FDA Label Image

Vial (Milrinone Lactate Injection 2)

Milrinone Lactate Injection 10 mg/10 mL (1 mg/mL) single-dose vial label from Hikma Pharmaceuticals USA Inc. The label indicates intravenous use only and includes dosage and storage instructions, as well as manufacturer and distributor details.*

FDA Label Image

Shelfpack (Milrinone Lactate Injection 3)

Milrinone Lactate Injection label for 20 mL single dose vial containing 1 mg/mL milrinone lactate solution for intravenous use. The label indicates storage instructions and lack of preservative. It shows the labeler as Hikma Pharmaceuticals USA Inc., with manufacturing in Portugal and distribution by West-Ward Pharmaceutical Corp in Eatontown, NJ.*

FDA Label Image

Vial (Milrinone Lactate Injection 4)

Milrinone Lactate Injection 1 mg/mL in a 50 mL single dose vial label by Hikma Pharmaceuticals USA Inc. The label includes dosage form (injection, solution), intravenous route, storage instructions, and usage limitations. The concentration is noted as 50 mg per 50 mL (1 mg/mL). The label also provides NDC 0143-9708-01 and manufacturer distribution details.*

FDA Label Image

Carton 10 X 50 mL (Milrinone Lactate Injection 5)

The image shows a medication label panel for Milrinone Lactate Injection, Solution. It includes a QR code on the left side and printed text with GTIN, serial number, expiration date, and lot number information on the right side. The label is for the 1 mg/mL strength from Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Carton (Milrinone Lactate Injection 6)

Packaging label for Milrinone Lactate Injection, USP 50 mg per 50 mL (1 mg/mL) intravenous solution. The label indicates it is preservative-free, for intravenous use only, and supplied as a single 50 mL dose vial. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc. The label includes storage instructions and usage notes.*

FDA Label Image

Vial (Milrinone Lactate Injection 7)

Label for Milrinone Lactate Injection, USP 1 mg/mL (10 mg per 10 mL) single dose vial, for intravenous use only. The label includes the strength, volume, route, and usage instructions. It also lists Hikma Pharmaceuticals USA Inc. as the labeler. Storage instructions and preservative status are provided along with NDC 0143-9710-01.*

FDA Label Image

10 mg Per 10 mL Shelfpack (Milrinone Lactate Injection 8)

Milrinone Lactate Injection, USP 10 mg per 10 mL (1 mg/mL) intravenous solution by Hikma Pharmaceuticals USA Inc. The label indicates preservative-free, supplied as 10 single-dose vials of 10 mL each. The label includes storage instructions and a barcode, with a NDC of 0143-9710-10.*

FDA Label Image

Carton (Milrinone Lactate Injection 9)

Packaging label for Milrinone Lactate Injection, USP 1 mg/mL (10 mg per 10 mL) intravenous solution by Hikma Pharmaceuticals USA Inc. The label specifies preservative-free solution in 10 mL single-dose vials, with 25 vials per package. It includes storage instructions and a barcode on the back panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.